Funding for this research was provided by:
Kuwait Foundation for the Advancement of Sciences
Text and Data Mining valid from 2018-11-12
Received: 17 July 2018
Accepted: 19 October 2018
First Online: 12 November 2018
Ethics approval and consent to participate
: Ethics approval given by the Ethics Committee at the Dasman Diabetes Institute, Kuwait RA/049/2012, 10/06/2012. All participants gave written informed consent before enrolling in the study.
: Not applicable.
: KI has received speaking fees for Janssen, Eli-Lilly, Novo Nordisk and Sanofi. Otherwise the study team has no competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.